KSI-101
An investigational, high-strength, bispecific protein designed to treat macular edema secondary to inflammation (MESI), for which no approved intravitreal biologic exists today
An investigational, high-strength, bispecific protein designed to treat macular edema secondary to inflammation (MESI), for which no approved intravitreal biologic exists today